Merck said March 17 its chief marketing officer, Mike Nally, will leave the drugmaker at the end of the month. Mr. Nally is leaving Merck to take a leadership role with another company, according to ...

The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.

Merck's BioReliance® testing services support Genetix' gene therapy commercialization.

Gossamer Bio has experienced numerous ups and downs over the years, including a clinical setback and significant staff reductions. Now, as it pursues potential approval for a heart drug, the company ...

Q1 2026 Management View "We delivered year-over-year growth with revenue of $16.3 billion, driven by continued strength in oncology, animal health and growing contributions from new products," said ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Merck’s first quarter results were shaped by robust momentum in its oncology and animal health divisions, as well as ...

Pharma marketing maven Arpa Garay is swapping the pharma C-suite for the biotech one. Moderna has wooed the 16-year Merck vet to join as chief commercial officer, the company said Wednesday. As part ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Google Cloud today announced a landmark partnership to enhance Merck's digital backbone as an AI-enabled enterprise. This ...